US health officials are reportedly reexamining a $590 million agreement awarded to Moderna (Nasdaq: MRNA) for the development ...
U.S. health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
Moderna shares fell 3% Thursday afternoon, after reports that federal health officials are re-evaluating the company’s $590 million contract to help develop a bird-flu vaccine. Moderna was awarded the ...
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
The Department of Health and Human Services is re-evaluating a $590 million contract for avian influenza mRNA vaccines that ...
A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...
The FDA canceled a vaccine advisory committee meeting to discuss influenza virus strains that should be included in shots for ...
Shares of vaccine maker Moderna dropped more than 5% late Wednesday after reports that the Health and Human Services ...
U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna (NASDAQ:MRNA) by the ...
American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...
U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results